“Hormesis”—An Inappropriate Extrapolation from the Specific to the Universal

References

• Renner R. Redrawing the dose-response curve. Environ Sci Technol. 2004; 38 (5): 90A-95A.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ, Baldwin LA. Toxicology rethinks its central belief. Nature. 2003; 421: 691–2.
   PubMed Web of Science ®Google Scholar
• Kaiser J. Hormesis. Sipping from a poisoned chalice. Science. 2003; 302: 376–9.
   PubMed Web of Science ®Google Scholar
• Kaiser J. Hormesis. A healthful dab of radiation? Science. 2003; 302:78.
   Google Scholar
• Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect. 2003; 111: 994–1006.
   Google Scholar
• Calabrese EJ, Baldwin LA. Defining hormesis. Hum Exp Toxi-col. 2002; 21: 91–7.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ. Expanding the RfD concept to incorporate and optimize beneficial effects while preventing toxic responses from non-essential toxicants. BELLE Newsletter. 1995: 4.
   Google Scholar
• Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolu-tion. Annu Rev Pharmacol Toxicol. 2003; 43: 175–97.
   PubMed Web of Science ®Google Scholar
• Juni RL, McElveen JC Jr. Environmental law applications of hormesis concepts: risk assessment and cost-benefit implica-tions. J Appl Toxicol. 2000; 20: 149–55.
   Google Scholar
• Kociba RJ, Keyes DG, Beyer JE, et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetra-chlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978; 46: 279–303.
   PubMed Web of Science ®Google Scholar
• Rier SE, Martin DC, Bowman RE, Domowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca raulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993; 21: 433–41.
   PubMedGoogle Scholar
• Schwartz GG, Ifyasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Dia-betes Care. 2003; 26: 468–70.
   PubMed Web of Science ®Google Scholar
• Kanter M, Yoruk M, Koc A, Meral I, Karaca T. Effects of cad-mium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic preg-nant rats. Biol Trace Elem Res. 2003; 93: 189–200.
   PubMed Web of Science ®Google Scholar
• Han JC, Park SY, Hah BG, et al. Cadmium induces impaired glu-cose tolerance in rat by down-regulating GLUT4 expression in adipocytes. Arch Biochem Biophys. 2003; 413: 213–20.
   PubMed Web of Science ®Google Scholar
• Merali Z, Singhal RL. Diabetogenic effects of chronic oral cad-mium adminstration to neonatal rats. Br J Pharmacol. 1980; 69: 151–7.
   PubMed Web of Science ®Google Scholar
• Goyer R. Toxic effects of metals. In: Amdur M, Doull J, Klaassen C. Casarett and Doull's Toxicology, The Basic Science of Poisons. 4th ed. New York: McGraw-Hill, Inc, 1991.
   Google Scholar
• Sood B, Delaney-Black V, Covington C, et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose-response effect. Pediatrics. 2001; 108: E34.
   Google Scholar
• Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA. 2003; 290: 2996–9.
   PubMed Web of Science ®Google Scholar
• Smith-Warner SA, Spiegelman D, Yaun S-S, et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA. 1998; 279: 535–40.
   PubMed Web of Science ®Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for lead: Health effects chapter. 1999.
   Google Scholar
• National Research Council (NRC). Toxicological Effects of Methylmercury. Washington, DC: National Academy Press, 2000.
   Google Scholar
• Ginsberg G, Hattis D, Sonawane B, et al. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol Sci. 2002; 66: 185–200.
   PubMed Web of Science ®Google Scholar
• Hattis D, Ginsberg G, Sonawane B, et al. Differences in phar-macokinetics between children and adults-II. Children's vari-ability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal. 2003; 23: 117–42.
   Google Scholar
• Huila JE, Miller MS, Taylor JA, et al. Symposium overview: the role of genetic polymorphism and repair deficiencies in envi-ronmental disease. Toxicol Sci. 1999; 47: 135–43.
   PubMed Web of Science ®Google Scholar
• Ecobichon DJ, Stephens DS. Perinatal development of human blood esterases. Clin Pharmacol Ther. 1973; 14: 41–7.
   PubMed Web of Science ®Google Scholar
• Chen J, Kumar M, Chan W, Berkowitz G, Wetmur JG. Increased influence of genetic variation on PON1 activity in neonates. Environ Health Perspect. 2003; 111: 1403–9.
   PubMed Web of Science ®Google Scholar
• Wang X, Huang J, Fan Z, et al. Genetic and environmental fac-tors associated with plasma paraoxonase activity in healthy Chi-nese. Int J Mol Med. 2004; 13: 445–50.
   PubMed Web of Science ®Google Scholar
• Gouedard C, Koum-Besson N, Barouki R, Morel Y. Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofi-brate and statins. Mol Pharmacol. 2003; 63: 945–56.
   PubMed Web of Science ®Google Scholar
• Sams C, Mason HJ. Detoxification of organophosphates by A-esterases in human serum. Hum Exp Toxicol. 1999; 18: 653–8.
   PubMed Web of Science ®Google Scholar
• Ginsberg G, Smolenski S, Hattis D, Sonawane B. Population dis-tribution of aldehyde dehydrogenase-2 genetic polymorphism: implications for risk assessment. Regul Toxicol Pharmacol. 2002; 36: 297–309.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Second National Report on Human Exposure to Environmental Chem-icals (released January 31, 2003).
   Google Scholar
• Environmental Working Group (EWG). Body Burden: The Pol-lution in People. 2003.
   Google Scholar
• Schecter A, Pavuk M, Papke O, Ryan B, Birnbaum L, Rosen R. Polybrominated diphenyl ethers (PBDEs) in U.S. mothers' milk. Environ Health Perspect. 2003; 111: 1723–9.
   PubMed Web of Science ®Google Scholar
• 3M. Analysis of pooled human sera and plasma and monkey sera for fluorocarbons using exygen method ExM-023-071. Report prepared for 3M, St. Paul, MN, by Exygen Research, State College, PA. Sponsor study number E02-1071; Exygen Study Number: 023-082 EPA docket AR226-1152. 2002.
   Google Scholar
• Olsen OW, Burris JM, Lundberg JK, Hansen KJ, Mandel JH, Zobel LR. Final report: Identification of fluorochemicals in human sera. III. Pediatric participants in a group A streptococci clinical trial investigation. Study conducted by Corporate Occupational Medicine, Medical Department, 3M Company. EPA Docket AR226-1085. 2002.
   Google Scholar
• Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusco TA,Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 pg per deciliter. N Engl J Med. 2003; 348: 1517-26.
   Google Scholar
• Vainio H, Miller AB. Primary and secondary prevention in col-orectal cancer. Acta Oncol. 2003; 42: 809–15.
   PubMed Web of Science ®Google Scholar
• Werner M, Kelsberg G, Weismantel AM, Aitken PV. Which healthy adults should take aspirin? J Fam Pract. 2004; 53: 146–50.
   Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical prac-tice. BMJ. 2004; 328: 434.
   PubMed Web of Science ®Google Scholar
• Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reyes' syndrome warning. Final rule. Fed Reg. 2003; 68: 18861–9
   Google Scholar
• Jacobson JM, et al. Thalidomide for the treatment of oral apht-hous ulcers in patients with HIV infection. N Engl J Med. 1997; 337: 1086–7.
   PubMedGoogle Scholar
• Krimskey S. Science in the Private Interest. New York: Rowrnan and Littlefield, 2003.
   Google Scholar
• National Toxicology Program (NTP). The 9th Report on Car-cinogens (ROC) Listing of Tamoxifen as a Known Human Car-cinogen: Fact Sheet. 2000.
   Google Scholar
• Harvey PW, Darbre P. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? J Appl Toxicol. 2004; 24: 167–76.
   Google Scholar
• Texas Institute for Advancement of Chemical Technology (TIACT). Chemical hormesis: beneficial effects at low exposures, adverse effects at high exposures. College Station, TX, 1998.
   Google Scholar